Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 08:14:24 31/07/26 pm AEST			5-day change	1st Jan Change
2,514.70 ^INR	-0.77%		+1.11%	+36.58%

15/05	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
15/05	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	191,147	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	25.57%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	191,147	191,147	191,147
Change	-	68.55%	-12.11%	120.88%	52.16%	25.57%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	26.8x	23.5x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.34x	3.95x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.7x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.68x	6.81x
EV / Revenue	0x	0x	0x	0x	0x	8.98x	7.68x	6.81x
EV / EBITDA	0x	0x	0x	0x	0x	25.8x	22.2x	19.5x
EV / EBIT	0x	0x	0x	-	0x	24.6x	20.5x	17.8x
EV / FCF	0x	0x	0x	0x	0x	50.3x	34.8x	35.3x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.88%	2.83%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,514.70	2,514.70	2,514.70
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	6/5/21	12/5/22	27/5/23	16/5/24	15/5/25	14/5/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	31.25x	-	-	-	2.02B
SUN PHARMACEUTICAL INDUSTRIES LTD.	36.67x	6.94x	23.96x	0.79%	50.29B
OTSUKA HOLDINGS CO., LTD.	18.61x	2.11x	9.96x	1.29%	37.24B
CIPLA LIMITED	28.47x	3.48x	18.01x	0.87%	12.41B
ZYDUS LIFESCIENCES LIMITED	26.43x	3.9x	15.89x	0.6%	11.65B
KRKA, D. D.	19.26x	3.37x	12.09x	3.46%	9.17B
ONO PHARMACEUTICAL CO., LTD.	16.27x	2.1x	7.07x	3.19%	7.24B
GEDEON RICHTER	8.2x	1.92x	5.03x	5.29%	6.8B
GLENMARK PHARMACEUTICALS LIMITED	33.25x	3.78x	16.08x	0.24%	6.47B
Average	24.27x	3.45x	13.51x	1.96%	15.92B
Weighted average by Cap.	26.71x	4.24x	16.17x	1.4%